Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumab
| Image |  |
|---|---|
| Description | scientific article published on 31 July 2019 |
| Author/s |
author: Christopher Nevala-Plagemann |
| Publication date | July 31, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |